止眩汤联合甲磺酸倍他司汀片治疗眩晕综合征临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R255.3

基金项目:


Clinical Study on Zhixuan Tang Combined with Betahistine Mesylate Tablets for Vertigo Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察自拟止眩汤联合甲磺酸倍他司汀片治疗眩晕综合征的临床疗效。方法:选取眩晕综合征患者96 例,按随机数字表法分成对照组与观察组各48 例。对照组给予甲磺酸倍他司汀片治疗,观察组在对照组的基础上口服止眩汤。2 组疗程均为7 d,分别于治疗前后评价2 组中医证候积分,记录眩晕消失时间及治疗期间不良反应情况;随访1 个月,统计2 组症状复发情况。结果:观察组总有效率为95.83%,对照组为83.33%,2 组比较,差异有统计学意义(P<0.05)。治疗后,2 组中医证候积分均较治疗前降低(P<0.05),且观察组中医证候积分明显低于对照组(P<0.05)。观察组眩晕消失时间为(3.66±0.58) d,对照组为(4.73±0.69) d,2 组比较,差异有统计学意义(P<0.05)。随访1 个月, 观察组复发率为5.00%, 对照组为41.67%,2 组比较,差异有统计学意义(P<0.05)。治疗期间,2 组仅部分患者出现轻微胃肠道不适,均未作处理自行消失。结论:止眩汤联合甲磺酸倍他司汀片治疗眩晕综合征能提高临床疗效,改善患者主要临床症状,加快病情康复,降低复发率,且无明显不良反应。

    Abstract:

    Abstract:Objective:To observe the clinical effect of the therapy of Zhixuan tang combined with betahistine mesylate tablets on vertigo syndrome. Methods: A total of 96 patients with vertigo syndrome were selected and divided into the observation group and the observation group according to the random number table method,with 48 cases in each group. The control group was treated with betahistine mesylate tablets;The observation group took Zhixuan Decoction on the basis of the control group.Both groups were treated for seven days. Before and after treatment,the Chinese medicine syndrome scores in the two groups were evaluated. The adverse reactions during treatment and disappearance time of vertigo were recorded. The patients were followed up for one month,and the recurrence of symptoms in the two groups was counted. Results:The total effective rate was 95.83% in the observation group and was 83.33% in the control group,the difference being significant(P<0.05). After treatment,the Chinese medicine syndrome scores in the two groups were decreased when compared with those before treatment(P<0.05), and the Chinese medicine syndrome score in the observation group was significantly lower than that in the control group(P<0.05). The average disappearance time of vertigo in the observation group was(3.66±0.58) days,and was(4.73±0.69) days in the control group,the difference being significant(P<0.05). After twomonth follow- up,the recurrence rate was 5.00% in the observation group,and was 41.67% in the control group,there being no significance in the difference(P>0.05). During the treatment, only some patients in the two groups had mild gastrointestinal discomfort and disappeared without treatment. Conclusion: The therapy of Zhixuan tang combined with betahistine mesylate tablets for vertigo syndrome can improve the clinical effects and the main clinical symptoms,accelerate the recovery of the disease,and reduce the recurrence rates,with no obvious adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

丁珺云,张小罗.止眩汤联合甲磺酸倍他司汀片治疗眩晕综合征临床研究[J].新中医,2022,54(2):23-26

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-01-22
  • 出版日期: